These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 5654208

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Irreversible enzyme inhibitors. CXIV. Proteolytic enzymes. IV. Additional active-site-directed irreversible inhibitors of alpha-chymotrypsin derived from phenoxyacetamides bearing a terminal sulfonyl fluoride.
    Baker BR, Hurlbut JA.
    J Med Chem; 1968 Mar; 11(2):241-5. PubMed ID: 5654209
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Irreversible enzyme inhibitors. CXL. Active-site-directed irreversible inhibitors derived from 1-(3-chlorophenyl)-4,6-diamino-1,2-dihydro-2,2-dimethyl-s-triazine.
    Baker BR, Lourens GJ.
    J Med Chem; 1969 Jan; 12(1):95-101. PubMed ID: 5763050
    [No Abstract] [Full Text] [Related]

  • 6. Irreversible enzyme inhibitors. CXLIV. Proteolytic enzymes. VII. Additonal active-site-directed irreversible inhibitors of trypsin derived from m- and p-(phenoxyalkoxy)benzamidines with a terminal sulfonyl fluoride.
    Baker BR, Erickson EH.
    J Med Chem; 1969 Jan; 12(1):112-7. PubMed ID: 5763005
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. 2-phenylethaneboronic acid, a possible transition-state analog for chymotrypsin.
    Koehler KA, Lienhard GE.
    Biochemistry; 1971 Jun 22; 10(13):2477-83. PubMed ID: 5557796
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Irreversible enzyme inhibitors. 143. Active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-aminophenoxypropyl)-2,4-diamino-6-methylpyrimidine with a terminal sulfonyl fluoride.
    Baker BR, Meyer RB.
    J Med Chem; 1969 Jan 22; 12(1):108-11. PubMed ID: 5763004
    [No Abstract] [Full Text] [Related]

  • 14. Irreversible enzyme inhibitors. CXLII. Further studies on active-site-directed irreversible inhibitors of dihydrofolic reductase derived from 5-(p-Aminophenoxypropyl)-2,4,6-triaminopyrimidine bearing a terminal sulfonyl fluoride.
    Baker BR, Meyer RB.
    J Med Chem; 1969 Jan 22; 12(1):104-7. PubMed ID: 5763003
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Irreversible enzyme inhibitors. CVII. Proteolytic enzymes. II. Bulk tolerance within chymotrypsin-inhibitor complexes.
    Baker BR, Hurlbut JA.
    J Med Chem; 1967 Nov 22; 10(6):1129-33. PubMed ID: 6056042
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Irreversible enzyme inhibitors. CXXXIV. Effect of ring substitution on the selective irreversible inhibition of dihydrofolic reductase from L1210 mouse leukemia and liver by 2,4-diamino-5-(3,4-dichlorophenyl)-6-[p-(m-fluorosulfonyl-phenylureido)phenoxymethyl]pyrimidine.
    Baker BR, Vermeulen NM.
    J Med Chem; 1969 Jan 22; 12(1):74-8. PubMed ID: 5763044
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.